Comment on

• Comparison of phenobarbitone and ursodeoxycholic acid in drug-augmented hepatobiliary scintigraphy for excluding the diagnosis of obstructive cholestasis in neonatal cholestasis syndrome.

  Malik D, Khan SH, Ali SW, Rather TA, Pakala R, Hassan MU, Yadav N, Pasupula M. Malik D, et al. Nucl Med Commun. 2015 Aug;36(8):827-32. doi: 10.1097/MNM.0000000000000322. Nucl Med Commun. 2015. PMID: 25920049
• Drug augmented hepatobiliary scintigraphy for evaluation of neonatal cholestasis: what does the evidence point to?

  Sadeghi R. Sadeghi R. Nucl Med Commun. 2015 Sep;36(9):965. doi: 10.1097/MNM.0000000000000356. Nucl Med Commun. 2015. PMID: 26214531 No abstract available.